NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

AIDS Vaccine Week


Susan Hasty, Publisher
Table of Contents . . . September 22nd, 2008
Non-Subscriber - Summaries Only
Related Areas: Other Issues in AIDS Vaccine Week | Other Publications

Gladstone Institutes - Gladstone scientists identify genetic link that may neutralize HIV

NIH/National Institute of Allergy and Infectious Diseases - Study reveals link between Apobec3 gene and neutralizing antibody response to retrovirus

Gene Therapy - Research in the area of gene therapy reported from University of Regensburg

DNA Vaccines - University of Cape Town, Department of Clinical Laboratory Sciences reports research in DNA vaccines

HIV/AIDS - New HIV Protection for Women

Pediatrics - Calvin B. Johnson, MD, MPH, Appointed Vice President & Chief Medical Officer for Temple University Health System

World Journal of Gastroenterology - A potential approach to treatment of hepatitis B virus infection



Return to Top of Page

-----------------------
PR Login